Results 151 to 160 of about 301,386 (199)

A phase Ib/II trial of neoadjuvant neratinib added to standard therapy in patients with HER2-positive or HR-positive/HER2-negative inflammatory breast cancer (including stage III and IV disease). [PDF]

open access: yesTher Adv Med Oncol
Lim B   +19 more
europepmc   +1 more source

“Inflammatory” breast cancer

open access: yesSurgical Oncology, 2005
"Inflammatory" breast cancer is a rare and very aggressive form of the disease characterised by rapid onset and dismal outcome.This review describes the clinical and molecular aspects of inflammatory breast cancer. The relevant English language literature on of inflammatory breast cancer was searched via Medline and ISI Web of Knowledge Cross Search ...
Cariati, M   +3 more
core   +7 more sources

The immunogram of inflammatory breast cancer

Cancer Treatment Reviews, 2023
Inflammatory breast cancer (IBC) is the most aggressive and fatal clinical presentation of breast cancer. Despite the term "inflammatory", based on the clinical presentation, IBC is biologically driven by an immunosuppressive tumor microenvironment (TME).
Valenza, Carmine   +6 more
openaire   +2 more sources

Inflammatory Breast Cancer

Seminars in Radiation Oncology, 2009
Inflammatory breast cancer (IBC) represents the most virulent form of breast cancer, characterized by involvement of the skin and rapid progression of the disease. Management involves careful coordination of all multidisciplinary modalities, including imaging, systemic chemotherapy, surgery, and radiation therapy.
Wendy A, Woodward   +1 more
openaire   +3 more sources

Inflammatory Breast Cancer

Archives of Surgery, 1991
Historically, the prognosis of inflammatory breast cancer has been poor. We conducted a retrospective review to evaluate the recent Memorial Sloan-Kettering Cancer Center experience, to evaluate the role of combination chemotherapy, and to compare the effect of surgery and radiation on local/regional failure.
M P, Moore   +4 more
openaire   +3 more sources

Inflammatory Breast Cancer

Journal of the National Comprehensive Cancer Network, 2011
Inflammatory breast cancer (IBC) represents the most virulent form of breast cancer, characterized by involvement of the skin and rapid progression of the disease. Management involves careful coordination of multidisciplinary modalities, including imaging, systemic chemotherapy, surgery, and radiation therapy.
Holly, Dushkin, Massimo, Cristofanilli
openaire   +3 more sources

INFLAMMATORY BREAST CANCER

Surgical Clinics of North America, 1996
Multimodal therapy with induction chemotherapy has improved significantly local disease control and overall survival in patients with IBC. This is now considered standard therapy for patients with this disease. Although survival has been improved, well over 50% of these patients will succumb to this disease. Ongoing and future investigations may better
M J, Lopez, K A, Porter
openaire   +2 more sources

Inflammatory Breast Cancer

Surgical Clinics of North America, 1985
Of all malignancies in women, perhaps none is as lethal or as frustrating to the surgeon as inflammatory breast cancer. No significant progress in curing or controlling inflammatory breast cancer was made until the last decade, when investigators, noting the futility of local therapies, applied systemic therapies with some significant improvement in ...
W R, Grace, A M, Cooperman
openaire   +2 more sources

Home - About - Disclaimer - Privacy